Introduction to IntroDia^™

In 2013, Boehringer Ingelheim and Eli Lilly and Company, in partnership with the International Diabetes Federation, announced the launch of IntroDia^™, the largest multinational survey in Type 2 Diabetes to date. Find out more about IntroDia^™, the importance of exploring early treatment conversations, the impact these conversations have on the management of T2D and what value the outcomes of the survey will bring to physicians and people living with T2D around the world.